- Tytuł :
- Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML
- Autorzy :
- Temat :
-
gemtuzumab ozogamicin
glasdegib
acute myeloid leukemia
measurable residual disease
Medicine (General)
R5-920 - Źródło :
- Trials, Vol 22, Iss 1, Pp 1-13 (2021)
- Opis pliku :
- electronic resource
- Relacje :
- https://doaj.org/toc/1745-6215
- Dostęp URL :
- https://doaj.org/article/de39e7989b1540d2a1eb5143a0cffc57
-
Czasopismo naukowe